drugset / Trial / NCT00290043
Glulisine Pre- and Postmeal
RandomizedCrossoverOpen-labelTreatment
Summary
To investigate in type 1 diabetic patients the glucodynamic response to HMR1964 insulin and RHI (HOE31HPR100) injected subcutaneously before and after a standard meal
Timeline
- Start
- 2001-12
- Primary completion
- —
- Completion
- 2002-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin glulisine | Protein / enzyme biologic | 0.15 iu/kg | Subcutaneous |